Global Recombinant Vaccines Market to Surpass US$ 1,809.7 Million by 2030 - Coherent Market Insights
SEATTLE, June 22, 2022 /PRNewswire/ --According to Coherent Market Insights, the global recombinant vaccines market is estimated to be valued at US$ 1,116.1 million in 2022 and is expected to exhibit a CAGR of 6.2% during the forecast period (2022-2030).
- SEATTLE, June 22, 2022 /PRNewswire/ --According to Coherent Market Insights, the global recombinant vaccines market is estimated to be valued at US$ 1,116.1 million in 2022 and is expected to exhibit a CAGR of 6.2% during the forecast period (2022-2030).
- Key Trends and Analysis of the Global Recombinant Vaccines Market:
Major players operating in market are focusing on adopting strategies such as product approvals, which is expected to drive market growth over the forecast period. - Global recombinant vaccines market is expected to exhibit a CAGR of 6.2% during the forecast period due to increasing prevalence of various infections such as hepatitis B.
- Among product types, the subunit recombinant vaccines segment is expected to dominate segment growth over the forecast period, owing to increased patent applications and allowance to key players for subunit recombinant vaccines.